ABEONA THERAPEUTICS INC. Shareholders' Equity
ABEONA THERAPEUTICS INC. (ABEO) had Shareholders' Equity of $128.06 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $128.06M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $144.94M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $159.22M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $171.23M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $128.06M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $144.94M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $159.22M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $171.23M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $163.58M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $41.40M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $44.03M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $45.77M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $73.24M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | -$8.88M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $14.83M 10-K · filed 2026-03-17 | |
| 2023-09-30 | $22.04M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $9.35M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $18.74M 10-Q · filed 2024-08-12 | |
| 2022-12-31 | $26.76M 10-K · filed 2025-03-20 | |
| 2022-09-30 | $12.40M 10-Q · filed 2023-11-13 | $15.41M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $14.02M 10-Q · filed 2023-11-13 | $20.09M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $21.18M 10-Q · filed 2023-08-08 | $31.44M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $42.37M 10-K · filed 2024-03-18 | $51.38M 10-K · filed 2022-03-31 |
| 2021-09-30 | $79.74M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $84.09M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $94.39M 10-Q · filed 2022-08-11 | |
| 2020-12-31 | $102.55M 10-K · filed 2023-03-29 | |
| 2020-09-30 | $115.11M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $121.05M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $132.38M 10-Q · filed 2021-07-28 | |
| 2019-12-31 | $178.43M 10-K · filed 2022-03-31 | |
| 2019-09-30 | $96.05M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $107.16M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $117.79M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $134.04M 10-K · filed 2021-03-24 | |
| 2018-09-30 | $150.25M 10-Q · filed 2019-11-12 | $150.25M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $160.92M 10-Q · filed 2019-11-12 | $160.91M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $169.74M 10-Q · filed 2019-11-12 | $169.20M 10-Q · filed 2018-05-10 |
| 2018-01-02 | $6.30M 10-K · filed 2020-03-16 | $170.10M 10-Q · filed 2018-05-10 |
| 2018-01-01 | $176.37M 10-K · filed 2019-03-18 | |
| 2017-12-31 | $170.10M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $89.88M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $89.08M 10-Q · filed 2017-11-14 | |
| 2017-03-31 | $95.71M 10-Q · filed 2017-11-14 | |
| 2016-12-31 | $99.10M 10-K · filed 2020-03-16 | |
| 2016-09-30 | $63.48M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $61.48M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $65.66M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $67.72M 10-K · filed 2019-03-18 | |
| 2015-09-30 | $73.07M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $59.95M 10-Q · filed 2015-11-16 | |
| 2015-03-31 | $3.16M 10-Q · filed 2015-11-16 | |
| 2014-12-31 | $4.82M 10-K · filed 2017-03-30 | |
| 2014-09-30 | -$30.36M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$28.40M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$15.49M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$14.78M 10-K · filed 2016-03-30 | |
| 2013-09-30 | -$13.16M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$12.35M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$13.61M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$17.08M 10-K · filed 2015-03-31 | |
| 2012-09-30 | -$46.29M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$31.07M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$20.16M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$17.61M 10-K · filed 2013-03-20 | |
| 2011-09-30 | -$23.47M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$23.94M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$20.80M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |